Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats

Gut

Volumn 51, Issue 4, 2002, Pages 490-495

  Sherwood, P V ^a   Wibawa, J I D ^a   Atherton, J C ^a   Jordan, N ^b   Jenkins, D ^a   Barrett, D A ^a   Shaw, P N ^a   Spiller, Robin C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; IODOACETAMIDE; METRONIDAZOLE; OMEPRAZOLE; PENTAGASTRIN; PRONASE; STOMACH MUCIN;

ACID SECRETION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MALE; MUCOLYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ABSORPTION; STOMACH PH; THICKNESS;

AMOXICILLIN; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CLARITHROMYCIN; GASTRIC ACID; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HYDROGEN-ION CONCENTRATION; MALE; METRONIDAZOLE; MUCUS; RATS; RATS, WISTAR;

EID: 0036786134     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.4.490     Document Type: Article

References (25)

1. De Koster E, Devaster J-M, Vandenborre C, et al. A nine years surveillance of Hp resistance to macrolides and imidazoles. Gastroenterology 1999;116(4 part 2):A145.
2. Goddard AF. Getting to the route of Helicobacter pylori treatment. J Antimicrob Chemother 1998;42:1-3.
3. Lind T, Megraud F, Unge P, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999;116:248-53.
4. Spiller RC. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? Eur J Gastro Hepatol 1999;11(suppl 2):S25-8.
5. Labenz J, Leverkus F, Börsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-5.
6. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;88:505-9.
7. Bakken JS, Bruun JN, Gaustad P, et al. Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges. Antimicrob Agents Chemother 1986;30:481-4.
8. Akamatsu T, Gotoh A, Shimizu H, et al. Combination effect of pronase for eradication therapy against Helicobacter pylori. Gastroenterology 1998;112:A54.
9. Zala G, Wirth HP, Scwery St, et al. N-Acetylcyteine improves eradication of H. pylori by omeprazole/amoxicillin in cigarette smokers. Gastroenterology 1994;106:A215.
10. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
11. Li H, Kalies I, Mellgård B, et al. A rat model of chronic Helicobacter pylori infection. Studies of epithelial cell turnover and gastric ulcer healing. Scand J Gastroenterol 1998;33:370-8.
12. Hashimoto Y, Tsuiki S, Nisizawa K, et al. Action of proteolytic enzymes on purified bovine submaxillary mucin. Ann NY Acad Sci 1963;106:233-46.
13. Jordan N, Newton J, Pearson J, et al. A novel method for the visualization of the in situ mucus layer in rat and man. Clin Sci 1998;95:97-106.
14. Jessa MJ, Barrett DA, Shaw PN, et al. A rapid and selective high performance liquid chromatography method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. J Chromatography B 1996;677:374-9.
15. Miyazaki K, Ohtani K, Sunada K, et al. Determination of ampicillin, amoxicillin, cephalexin and cephradine in plasma by high-performance liquid chromatography using fluorescence detection. J Chromatography B 1983;276:478-82.
16. Chu S-Y, Sennello LT, Sonders RC. Simultaneous determination of clarithromycin and 14-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. J Chromatogr 1991;571:199-208.
17. Goddard AF, Jessa MJ, Barrett DA, et al. Effect of omeprazole on the distribution of metronidazole, amoxycillin and clarithromycin in human gastric juice. Gastroenterology 1996;111:358-67.
18. Goddard AF, Spiller RC. In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents. Antimicrob Agents Chemother 1997;41:1246-9.
19. Lozniewski A, Duprez A, Renault C, et al. Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model. Antimicob Agents Chemother 1999;43:1909-13.
20. Shore PA, Brodie BB, Hogben CAM. The gastric secretion of drugs: a pH partition hypothesis. J Pharm Exp Ther 1956;119:361-9.
21. Goddard AF, Sherwood PV. Bioavailability of antimicrobials after oral and parenteral administration. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers, 1998:392-7.
22. Fietta A, Merlini C, Gialdroni Grassi G. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. J Chemother 1997;9:23-31.
23. Newton JL, Jordan N, Pearson J, et al. The adherent gastric antral and duodenal mucus layer thins with advancing age in subjects infected with Helicobacter pylori. Gerontology 2000;46:153-7.
24. Kalia N, Bardhan KD, Read MW, et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. Dig Dis Sci 2000;45:763-72.
25. Mégraud F, Trimoulet P, Lamouliatte H, et al. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother 1991;35:869-72.